Fondation Médicale Reine Elisabeth

Mapping signature features and neuroanatomical correlates of hallucinations and delusions in neurodegenerative cognitive disorders

Cell-type selectivity of transcranial focused ultrasound for epilepsy treatmentC

The skull bone marrow: a novel player and therapeutic target in the brain–immune axis during meningitis

Breaking the Geometry of Cross-Dementia Landscape for Early Diagnosis and Drug Target Identification

Investigating Msh3 modulation as a novel therapeutic strategy for the treatment of Huntington’ Disease

Targeting Microglial MHCII and Regulatory T Cells to Modulate Alzheimer’s disease Progression

Dissecting the transcriptional regulatory landscape of TMEM106B

Synaptic Homeostasis and Autophagy Regulation in the Etiology of Parkinsonism

CALM-GBM: Circuit control by Astrocytes Located in Microenvironment of Glioblastoma

Identifying disease-critical neural cell types and pathways to guide new treatment approaches for Houge-Janssens syndrome type 2 (HJS2)

taVNS with iVR for stroke rehabilitation

Biomarker Research into Dysregulated Immunity in ALS (ALS-BRiDGE)

Clocking in foamy microglia to curb and reverse inflammatory demyelination

Targeting transforming growth factor beta 3‑driven phospholipid synthesis to enhance oligodendrocyte differentiation in multiple sclerosis

Uncovering the molecular basis of somatosensory neuron diversification

Implication of GnRH in the neocortical developmental alterations induced by endocrine disrupting chemicals